SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Jansson I) "

Sökning: WFRF:(Jansson I)

  • Resultat 51-60 av 242
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
51.
  •  
52.
  • Botusan, I. R., et al. (författare)
  • Deficiency of liver-derived insulin-like growth factor-I (IGF-I) does not interfere with the skin wound healing rate
  • 2018
  • Ingår i: PLoS ONE. - : Public Library of Science (PLoS). - 1932-6203. ; 13:3
  • Tidskriftsartikel (refereegranskat)abstract
    • Objective: IGF-I is a growth factor, which is expressed in virtually all tissues. The circulating IGF-I is however derived mainly from the liver. IGF-I promotes wound healing and its levels are decreased in wounds with low regenerative potential such as diabetic wounds. However, the contribution of circulating IGF-I to wound healing is unknown. Here we investigated the role of systemic IGF-I on wound healing rate in mice with deficiency of liver-derived IGF-I (LI-IGF-I-/- mice) during normal (normoglycemic) and impaired wound healing (diabetes). Methods: LI-IGF-I-/- mice with complete inactivation of the IGF-I gene in the hepatocytes were generated using the Cre/loxP recombination system. This resulted in a 75% reduction of circulating IGF-I. Diabetes was induced with streptozocin in both LI-IGF-I-/- and control mice. Wounds were made on the dorsum of the mice, and the wound healing rate and histology were evaluated. Serum IGF-I and GH were measured by RIA and ELISA respectively. The expression of IGF-I, IGF-II and the IGF-I receptor in the skin were evaluated by qRT-PCR. The local IGF-I protein expression in different cell types of the wounds during wound healing process was analyzed using immunohistochemistry. Results: The wound healing rate was similar in LI-IGF-I-/- mice to that in controls. Diabetes significantly delayed the wound healing rate in both LI-IGF-I-/- and control mice. However, no significant difference was observed between diabetic animals with normal or reduced hepatic IGF-I production. The gene expression of IGF-I, IGF-II and IGF-I receptor in skin was not different between any group of animals tested. Local IGF-I levels in the wounds were similar between of LI-IGF-I-/- and WT mice although a transient reduction of IGF-I expression in leukocytes in the wounds of LI-IGF-I-/- was observed seven days post wounding. Conclusion: Deficiency in the liver-derived IGF-I does not affect wound healing in mice, neither in normo-glycemic conditions nor in diabetes.
  •  
53.
  • Camuffo, I, et al. (författare)
  • Concepts definition
  • 2009
  • Rapport (övrigt vetenskapligt/konstnärligt)
  •  
54.
  • Camuffo, I, et al. (författare)
  • State of the art and eVALUE scope
  • 2008
  • Rapport (övrigt vetenskapligt/konstnärligt)abstract
    • eVALUE will address the real function of ICT-based safety systems and their capability to perform the function through two courses of action: defining and quantifying the function output to be achieved by the safety system and developing the testing and evaluation methods for the ICT-based safety systems. The safety systems within the eVALUE scope are classified into four clusters: longitudinal, lateral and yaw/stability. The fourth cluster remains open for upcoming systems. Based on market availability and penetration rate, the consortium decided to focus on eight preventive or mitigating safety systems: ACC, FCW and CM by braking, in the longitudinal assistance domain; BSD, LDW and LKA, in the lateral assistance domain; and finally, ABS and ESC, in the yaw/stability assistance domain. Following the description of current test and evaluation methods, sensor technologies, system function output and ECUs globally applicable to ICT based safety systems, the report covers these technologies and components for the eight selected systems in detail. As a next step to this deliverable and according to the work plan, concepts for design reviews, physical vehicle testing as well as laboratory testing will be analysed. The result will be an in-depth understanding of the possibilities to investigate and evaluate the eight active safety systems within the first phase of the project. The different concepts will then support the decision about the development of the testing and evaluation methods that are able to point out the safety benefit of those systems in the most representative way.
  •  
55.
  •  
56.
  •  
57.
  • Kahn, J, et al. (författare)
  • Overexpression of CXCR4 on human CD34(+) progenitors increases their proliferation, migration, and NOD/SCID repopulation
  • 2004
  • Ingår i: Blood. - : American Society of Hematology. - 1528-0020 .- 0006-4971. ; 103:8, s. 2942-2949
  • Tidskriftsartikel (refereegranskat)abstract
    • A major limitation to clinical stem cell-mediated gene therapy protocols is the low levels of engraftment by transduced progenitors. We report that CXCR4 overexpression on human CD34(+) progenitors using a lentiviral gene transfer technique helped navigate these cells to the murine bone marrow and spleen in response to stromal-derived factor 1 (SDF-1) signaling. Cells overexpressing CXCR4 exhibited significant increases in SDF-1-mediated chemotaxis and actin polymerization compared with control cells. A major advantage of CXCR4 overexpression was demonstrated by the ability of transduced CD34(+) cells to respond to lower, physiologic levels of SDF-1 when compared to control cells, leading to improved SDIF-1-induced migration and proliferation/survival, and finally resulting in significantly higher levels of in vivo repopulation of nonobese diabetic/severe combined immunodeficiency (NOD/SCID) mice including primitive CD34(+)/CD38(-/low) cells. Importantly, no cellular transformation was observed following transduction with the CXCR4 vector. Unexpectedly, we documented lack of receptor internalization in response to high levels of SDF-1, which can also contribute to increased migration and proliferation by the transduced CD34(+) cells. Our results suggest CXCR4 overexpression for improved definitive human stem cell motility, retention, and multilineage repopulation, which could be beneficial for in vivo navigation and expansion of hematopoietic progenitors.
  •  
58.
  • Kanoni, Stavroula, et al. (författare)
  • Analysis with the exome array identifies multiple new independent variants in lipid loci
  • 2016
  • Ingår i: Human Molecular Genetics. - : Oxford University Press (OUP). - 0964-6906 .- 1460-2083. ; 25:18, s. 4094-4106
  • Tidskriftsartikel (refereegranskat)abstract
    • It has been hypothesized that low frequency (1-5% minor allele frequency (MAF)) and rare (<1% MAF) variants with large effect sizes may contribute to the missing heritability in complex traits. Here, we report an association analysis of lipid traits (total cholesterol, LDL-cholesterol, HDL-cholesterol triglycerides) in up to 27 312 individuals with a comprehensive set of low frequency coding variants (ExomeChip), combined with conditional analysis in the known lipid loci. No new locus reached genome-wide significance. However, we found a new lead variant in 26 known lipid association regions of which 16 were >1000-fold more significant than the previous sentinel variant and not in close LD (six had MAF <5%). Furthermore, conditional analysis revealed multiple independent signals (ranging from 1 to 5) in a third of the 98 lipid loci tested, including rare variants. Addition of our novel associations resulted in between 1.5- and 2.5-fold increase in the proportion of heritability explained for the different lipid traits. Our findings suggest that rare coding variants contribute to the genetic architecture of lipid traits.
  •  
59.
  • Ledoux, X., et al. (författare)
  • The Neutrons for Science Facility at SPIRAL-2
  • 2014
  • Ingår i: Nuclear Data Sheets. - : Elsevier BV. - 0090-3752 .- 1095-9904. ; 119, s. 353-356
  • Tidskriftsartikel (refereegranskat)abstract
    • The Neutrons For Science (NFS) facility is a component of SPIRAL-2 laboratory under construction at Caen (France). SPIRAL-2 is dedicated to the production of high intensity Radioactive Ions Beams (RIB). It is based on a high-power linear accelerator (LINAG) to accelerate deuterons beams in order to produce neutrons by breakup reactions on a C converter. These neutrons will induce fission in U-238 for production of radioactive isotopes. Additionally to the RIB production, the proton and deuteron beams delivered by the accelerator will be used in the NFS facility. NFS is composed of a pulsed neutron beam and irradiation stations for cross-section measurements and material studies. The beams delivered by the LINAG will allow producing intense neutron beams in the 100 keV-40 MeV energy range with either a continuous or quasi-mono-energetic spectrum. At NFS available average fluxes will be up to 2 orders of magnitude higher than those of other existing time-of-flight facilities in the 1 MeV - 40 MeV range. NFS will be a very powerful tool for fundamental physics and application related research in support of the transmutation of nuclear waste, design of future fission and fusion reactors, nuclear medicine or test and development of new detectors. The facility and its characteristics are described, and several examples of the first potential experiments are presented.
  •  
60.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 51-60 av 242
Typ av publikation
tidskriftsartikel (198)
konferensbidrag (27)
rapport (6)
forskningsöversikt (4)
annan publikation (2)
doktorsavhandling (2)
visa fler...
licentiatavhandling (1)
recension (1)
visa färre...
Typ av innehåll
refereegranskat (211)
övrigt vetenskapligt/konstnärligt (29)
populärvet., debatt m.m. (1)
Författare/redaktör
Bai, X. (15)
Kumar, A. (15)
Kolanoski, H. (14)
Moore, R. W. (14)
Nagai, R. (14)
Neumann, M. (14)
visa fler...
Tollefson, K. (14)
Zhang, Z. (14)
Weigel, P. (14)
Schindler, S. (14)
Engel, R. (14)
Silva, M. (14)
Choi, S. (14)
Snihur, R. (14)
Kowalski, M. (14)
Van Eijndhoven, N. (14)
Ackermann, M. (14)
Adams, J. (14)
Aguilar, J. A. (14)
Barwick, S. W. (14)
Bay, R. (14)
Beatty, J. J. (14)
BenZvi, S. (14)
Berley, D. (14)
Bernardini, E. (14)
Besson, D. Z. (14)
Blaufuss, E. (14)
Chirkin, D. (14)
Cowen, D. F. (14)
De Clercq, C. (14)
Desiati, P. (14)
de Vries, K. D. (14)
de Wasseige, G. (14)
DeYoung, T. (14)
Diaz-Velez, J. C. (14)
Ehrhardt, T. (14)
Fazely, A. R. (14)
Fedynitch, A. (14)
Gerhardt, L. (14)
Gonzalez, J. G. (14)
Grant, D. (14)
Halzen, F. (14)
Hanson, K. (14)
Helbing, K. (14)
Hickford, S. (14)
Hoffman, K. D. (14)
Hoshina, K. (14)
Ishihara, A. (14)
Japaridze, G. S. (14)
Kappes, A. (14)
visa färre...
Lärosäte
Karolinska Institutet (93)
Uppsala universitet (76)
Göteborgs universitet (63)
Lunds universitet (53)
Umeå universitet (39)
Stockholms universitet (23)
visa fler...
Kungliga Tekniska Högskolan (17)
Linköpings universitet (16)
Chalmers tekniska högskola (15)
Linnéuniversitetet (8)
Mälardalens universitet (4)
Örebro universitet (3)
Sveriges Lantbruksuniversitet (3)
Jönköping University (2)
Mittuniversitetet (2)
Högskolan i Skövde (2)
VTI - Statens väg- och transportforskningsinstitut (2)
Luleå tekniska universitet (1)
Högskolan i Gävle (1)
Malmö universitet (1)
Södertörns högskola (1)
Högskolan i Borås (1)
RISE (1)
Karlstads universitet (1)
Högskolan Dalarna (1)
visa färre...
Språk
Engelska (233)
Svenska (8)
Odefinierat språk (1)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (88)
Naturvetenskap (59)
Samhällsvetenskap (11)
Teknik (9)
Lantbruksvetenskap (2)
Humaniora (2)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy